Post by
subaru1 on Jul 08, 2024 10:41am
Research and development
Pharmaceutical and Business to Business (“B2B”): This stream includes the production and sale of bulk cannabis concentrate based products such as dronabinol, concentrate, distillate and isolate to domestic and international customers. Bulk isolate includes pharmaceutical grade cannabinoids in isolate and finished good forms produced using our Canadian DEL and sold to pharmaceutical customers. For our pharma and academic partners, we also provide a range of clinical and research and development (“R&D”) capabilities including Clinical Trial Materials (CTM) for Phase 2-3 Drug Trials. Also included in this stream are contract manufacturing activities where we produce finished goods and various manufacturing steps for other licenced producers.
R&D they spend $54k in qrt1 , we can say that they don't develop to much with that amount only.